Mad in America: Rethinking Mental Health
Health & Fitness:Mental Health
Welcome to MIA Reports, showcasing our independent and original journalism devoted to rethinking psychiatry. We take selected MIA Reports and provide them as audio articles. Click here for the text version of this and all of our MIA reports.
The Whistleblower and Penn: A Final Accounting of Study 352
Written by Peter Simons, read by James Moore, first published on Mad in America, December 29, 2019.
Although the general story of ghostwriting in trials of psychiatric drugs is now pretty well known, the details of the corruption in specific trials are still emerging into the public record, often a decade or more after the original sin of fraudulent publication. The latest study to finally see the full light of day is GlaxoSmithKline’s study 352.
Perhaps the most infamous ghostwritten study is GSK’s study 329, which, in a 2001 report published in the American Journal of Psychiatry, falsely touted paroxetine (Paxil) as an effective treatment for adolescent depression. The company paid over $3 billion in penalties for fraud.
That same year, study 352 made its first appearance in the research literature. That was when Charles Nemeroff, who in the years ahead would become the public face of research misconduct, “authored” an article on the efficacy of paroxetine for bipolar disorder. It has taken 18 years for the full story of that corruption to become known, the final chapter recently emerging when a large cache of study 352 documents—emails, memos, and other internal correspondence between the key players—was made public.
The documents reveal a web of corruption that went beyond the fraud of ghostwriting into the spinning of negative results into positive conclusions, and the abetting of that corruption by an editor of the scientific journal that published the article. The documents also reveal a whitewashing of the corruption by the University of Pennsylvania.
However, it was the publication of these documents that provided Jay Amsterdam, an investigator in the trial who turned whistleblower after he smelled a rat, with a chance to say “case closed.” Amsterdam and Leemon McHenry have now published two articles that provide a step-by-step deconstruction of the study—the ghostwriting, the spinning of results, the betrayal of public trust.
Here is the story of that whistleblowing.
Trans Lifeline - Naming Trans-Specific Harm in Mental Health
Nicholas Haslam - Psych Concepts Creep Into Our Everyday Experiences
Allan Horwitz and Sarah Fay - The Impact the DSM Has Had On All of Us
Sera Davidow - Trusting People as Experts of Themselves
Lynne Layton - The Social Unconscious and Character Formation in Neoliberal Culture
Dana Becker - The Medicalization of Women’s Suffering
Michael Hengartner – Evidence-biased Antidepressant Prescription
Johann Hari: Stolen Focus – Why You Can’t Pay Attention
Elia Abi-Jaoude - Understanding the Youth Mental Health Crisis
Sebastienne Grant - Critical Psychology for a Better Society
For Life - Opera on Psychiatry and Its Drugs Premieres on Jan 15
Vincenzo Di Nicola - The Crisis in Psychiatry and The Slow Way Back
Oryx Cohen and Briza Gavidia - Emotional CPR - Heart-Centered Peer Support
Elisa Lacerda-Vandenborn - How Western Psychology Can Rip Indigenous Families Apart
Renee Schuls-Jacobson – Psychiatrized: Waking up After a Decade of Bad Medicine
Giovanni Fava - A Different Psychiatry is Possible
Hans Skott-Myhre - Can Critiques of Psychiatry Help us Imagine a Post-Capitalist Future?
Shira Collings - New Perspectives on Eating Disorders
Helena Hansen - Combatting Structural Racism and Classism in Psychiatry
Matcheri Keshavan and Raquelle Mesholam-Gately - Why Some Experts and Patients Want to Rename Schizophrenia
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Mental Health Insights
MQ Open Mind
Speaking of Suicide
The Suicide Prevention Movement
Depression Talks Podcast